Tech Company Financing Transactions

20/20 GeneSystems Funding Round

Keiretsu Forum - San Francisco, Ping An Group and private investors participated in a $4.5 million Series A venture round for 20/20 GeneSystems. This VC investment round closed on 1/14/2016.

Transaction Overview

Company Name
20/20 GeneSystems
Announced On
1/14/2016
Transaction Type
Venture Equity
Amount
$4,500,000
Round
Series A
Investors

Keiretsu Forum - San Francisco (Chris Apfel)

Ping An Group (Jian Zhang)

Proceeds Purpose
The company intends to use the funds to accelerate commercialization of lung cancer test in China. In particular, the funds will support 20/20's efforts to customize for the Chinese market its proprietary algorithm for blood biomarker testing for cancer. The algorithm will then be made available to hundreds of hospitals and Health Check centers throughout China using a cloud based software-as-a-service (SaaS) model.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9430 Key West Ave. 100
Rockville, MD 20850
USA
Phone
(240) 453-6339
Website
www.2020gene.com
Email Address
[email protected]
Overview
20/20 GeneSystems ('20/20') was founded in May of 2000 to develop and promote innovative tools for biotech.
Profile
20/20 GeneSystems LinkedIn Company Profile
Social Media
20/20 GeneSystems Company Twitter Account
Company News
20/20 GeneSystems News
Facebook
20/20 GeneSystems on Facebook
YouTube
20/20 GeneSystems on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jonathan Cohen
  Jonathan Cohen LinkedIn Profile  Jonathan Cohen Twitter Account  Jonathan Cohen News  Jonathan Cohen on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/14/2016: Foursquare venture capital transaction
Next: 1/14/2016: Insightpool venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.